Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis-Reference-Cited by-同舟云学术

Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis

Published:2021-08-11 Issue:9 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Herranz Carmen¹^ORCID,Mateo Francesca¹,Baiges Alexandra¹,Ruiz de Garibay Gorka¹^ORCID,Junza Alexandra²³,Johnson Simon R⁴^ORCID,Miller Suzanne⁴,García Nadia¹,Capellades Jordi²³,Gómez Antonio⁵^ORCID,Vidal August⁶⁷^ORCID,Palomero Luis¹,Espín Roderic¹,Extremera Ana I¹,Blommaert Eline¹,Revilla‐López Eva⁸,Saez Berta⁸,Gómez‐Ollés Susana⁸,Ancochea Julio⁹,Valenzuela Claudia⁹,Alonso Tamara⁹,Ussetti Piedad¹⁰,Laporta Rosalía¹⁰,Xaubet Antoni¹¹,Rodríguez‐Portal José A¹²¹³,Montes‐Worboys Ana¹³¹⁴,Machahua Carlos¹³¹⁴^ORCID,Bordas Jaume¹³¹⁴^ORCID,Menendez Javier A¹,Cruzado Josep M¹⁵¹⁶,Guiteras Roser¹⁵¹⁶,Bontoux Christophe¹⁷,La Motta Concettina¹⁸^ORCID,Noguera‐Castells Aleix¹⁹,Mancino Mario¹⁹,Lastra Enrique²⁰^ORCID,Rigo‐Bonnin Raúl²¹^ORCID,Perales Jose C²²,Viñals Francesc¹²²^ORCID,Lahiguera Alvaro¹,Zhang Xiaohu²³,Cuadras Daniel²⁴^ORCID,Moorsel Coline H M²⁵,Vis Joanne J²⁵,Quanjel Marian J R²⁵,Filippakis Harilaos²⁶^ORCID,Hakem Razq²⁷,Gorrini Chiara²⁸,Ferrer Marc²³,Ugun‐Klusek Aslihan²⁹^ORCID,Billett Ellen²⁹,Radzikowska Elżbieta³⁰^ORCID,Casanova Álvaro³¹,Molina‐Molina María¹³¹⁴,Roman Antonio⁸^ORCID,Yanes Oscar²³,Pujana Miquel A¹^ORCID

Affiliation:

1. ProCURE Catalan Institute of Oncology Oncobell Bellvitge Institute for Biomedical Research (IDIBELL) L’Hospitalet del Llobregat Barcelona Spain

2. Department of Electronic Engineering Institute of Health Research Pere Virgili (IIPSV) University Rovira i Virgili Tarragona Spain

3. Biomedical Research Network Centre in Diabetes and Associated Metabolic Diseases (CIBERDEM) Instituto de Salud Carlos III Madrid Spain

4. National Centre for Lymphangioleiomyomatosis Nottingham University Hospitals NHS Trust, Nottinghamshire Division of Respiratory Medicine University of Nottingham Nottingham UK

5. Centre for Genomic Regulation Barcelona Institute of Science and Technology Barcelona Spain

6. Department of Pathology University Hospital of Bellvitge Oncobell IDIBELL, L’Hospitalet del Llobregat Barcelona Spain

7. CIBER on Cancer (CIBERONC) Instituto de Salud Carlos III Madrid Spain

8. Lung Transplant Unit, Pneumology Service Lymphangioleiomyomatosis Clinic Vall d’Hebron University Hospital Barcelona Spain

9. Pneumology Service La Princesa Research Institute University Hospital La Princesa Madrid Spain

10. Pneumology Service University Hospital Clínica Puerta del Hierro, Majadahonda Madrid Spain

11. Pneumology Service Hospital Clínic de Barcelona Barcelona Spain

12. Medical‐Surgical Unit of Respiratory Diseases Institute of Biomedicine of Seville (IBiS) University Hospital Virgen del Rocío Seville Spain

13. Biomedical Research Network Centre in Respiratory Diseases (CIBERES) Instituto de Salud Carlos III Madrid Spain

14. Interstitial Lung Disease Unit Department of Respiratory Medicine University Hospital of Bellvitge IDIBELL L’Hospitalet del Llobregat Barcelona Spain

15. Experimental Nephrology Department of Clinical Sciences University of Barcelona Barcelona Spain

16. Department of Nephrology University Hospital of Bellvitge IDIBELL L’Hospitalet del Llobregat Barcelona Spain

17. Department of Pathology University Hospital Pitié‐Salpêtrière Faculty of Medicine University of Sorbonne Paris France

18. Department of Pharmacy University of Pisa Pisa Italy

19. Biomedical Research Institute “August Pi i Sunyer” (IDIBAPS) Department of Medicine University of Barcelona Barcelona Spain

20. Genetic Counseling Unit Department of Medical Oncology University Hospital of Burgos Burgos Spain

21. Clinical Laboratory University Hospital of Bellvitge IDIBELL L'Hospitalet de Llobregat Barcelona Spain

22. Department of Physiological Science II University of Barcelona Barcelona Spain

23. National Center for Advancing Translational Sciences (NCATS) National Institute of Health (NIH) Bethesda MD USA

24. Statistics Department Foundation Sant Joan de Déu Esplugues Spain

25. Interstitial Lung Disease (ILD) Center of Excellence St. Antonius Hospital Nieuwegein The Netherlands

26. Pulmonary and Critical Care Medicine Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA USA

27. Princess Margaret Cancer Centre University Health Network Department of Medical Biophysics University of Toronto Toronto Ontario Canada

28. Princess Margaret Hospital The Campbell Family Institute for Breast Cancer Research Ontario Cancer Institute University Health Network Toronto ON Canada

29. Centre for Health, Ageing and Understanding Disease (CHAUD) School of Science and Technology Nottingham Trent University Nottingham UK

30. Department of Lung Diseases III National Tuberculosis and Lung Disease Research Institute Warsaw Poland

31. Pneumology Service University Hospital of Henares University Francisco de Vitoria, Coslada Madrid Spain

Funder

LAM Foundation

ZonMw

Generalitat de Catalunya

Nottingham Trent University

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202113929

Reference92 articles.

1. Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target

2. Mast-Cell Tryptase Release Contributes to Disease Progression in Lymphangioleiomyomatosis

3. A 4-year prospective evaluation of protocols to improve clinical outcomes for patients with lymphangioleiomyomatosis in a national clinical centre

4. Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study

5. Role of Histamine in Modulating the Immune Response and Inflammation

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omics research in lymphangioleiomyomatosis: status and challenges;Expert Review of Respiratory Medicine;2024-09-11

2. Highlights del 57.° Congreso SEPAR;Open Respiratory Archives;2024-09

3. LncRNA MIR100HG affects the proliferation and metastasis of lung cancer cells through mediating the microRNA‐5590‐3p/DCBLD2 axis;Immunity, Inflammation and Disease;2024-04

4. Disorders of the Lymphatic System;Rook's Textbook of Dermatology;2024-03-19

5. The role of moesin in diagnosing and assessing severity of lymphangioleiomyomatosis;Respiratory Research;2024-01-25